The Nifty Pharma index tracks pharmaceutical manufacturers listed on NSE, including makers of branded generics for India, generic drugs for export markets and active pharmaceutical ingredients. It holds up to 20 stocks weighted by free-float market capitalisation.
A large share of sector revenue comes from the US generics market, so drug approvals and price erosion there, along with US FDA inspection outcomes at Indian plants, move the index. Domestic demand, new launches, raw material costs and currency movements are the other main drivers. The sector is usually treated as defensive because healthcare demand varies less with the economic cycle.